Six vaccine candidates in clinical trials for COVID-19 employ viruses to deliver genetic cargo that, once inside our cells, instructs them to make SARS-CoV-2 protein. This stimulates an immune ...
MOSCOW, August 4. /TASS/. All volunteers inoculated with the vaccine against the coronavirus developed by the Vektor State Research Center of Virology and Biotechnology are in good health, no side ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback